Measurement of lymph node function from the extraction of immunoglobulin in lymph. 2010

J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
Department of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK.

BACKGROUND We aimed to measure the extraction fraction of human immunoglobulin G (HIG) by the 1st echelon lymph node (sentinel node) following intradermal injection in patients with breast cancer undergoing axillary lymph node dissection (ALND) and examine its association with node size and presence and extent of nodal metastatic disease. METHODS HIG labelled with either In-111 (n = 21) or Tc-99m (n = 9) was injected intradermally at the areolar. ALND was performed 2-4 h later. All lymph nodes were isolated and individually counted in a well-counter. The counts in the 'hottest' (1st echelon) node were expressed as a fraction of total counts in all the resected nodes. Since counts in the least hot nodes barely exceeded background, this fraction represents extraction fraction for the 1st echelon node. Presence of disease was noted in each 1st echelon node and the extent quantified as percentage replacement with disease. RESULTS Median extraction fraction in 1st echelon nodes with no or low (<1%) disease burden (n = 21) was 68 (range 23-93)%, significantly higher (p < 0.05) than in diseased 1st echelon nodes (n = 9), in which it was 44 (21-66)%. There was, however, no association between extraction fraction in diseased nodes and disease extent. In nodes with no/low disease, extraction fraction was similar for the two radiolabels. There was no association between extraction fraction and node size. CONCLUSIONS Nodal extraction fraction of HIG is a novel physiological measurement. It is reduced as a result of metastatic invasion. In the absence of disease, it shows no correlation with node size.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008196 Lymph The interstitial fluid that is in the LYMPHATIC SYSTEM. Lymphs
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011868 Radioisotopes Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Daughter Isotope,Daughter Nuclide,Radioactive Isotope,Radioactive Isotopes,Radiogenic Isotope,Radioisotope,Radionuclide,Radionuclides,Daughter Nuclides,Daugter Isotopes,Radiogenic Isotopes,Isotope, Daughter,Isotope, Radioactive,Isotope, Radiogenic,Isotopes, Daugter,Isotopes, Radioactive,Isotopes, Radiogenic,Nuclide, Daughter,Nuclides, Daughter
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
September 2012, Annals of hematology,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
October 2015, Histopathology,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
December 1991, American journal of clinical pathology,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
April 2009, Journal of nutritional science and vitaminology,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
July 1991, American journal of clinical pathology,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
September 2012, Clinical and experimental immunology,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
September 2004, Nuclear medicine communications,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
September 1979, Journal of immunology (Baltimore, Md. : 1950),
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
December 1991, American journal of veterinary research,
J Charlotte Fowler, and Tom Bennett Britton, and Elena Provenzano, and Duraisamy Ravichandran, and David Lawrence, and Chandra K Solanki, and James R Ballinger, and Anthony Douglas-Jones, and Peter S Mortimer, and Arnie D Purushotham, and A Michael Peters
June 1967, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!